Literature DB >> 22225492

wbeT sequence typing and IS1004 profiling of Vibrio cholerae isolates.

A Sharifnia1, B Bakhshi, M R Pourshafie.   

Abstract

AIMS: To investigate the molecular basis for serotype variation in Vibrio cholerae O1 and the genetic relatedness amongst different serotypes isolated from 2004 to 2008 in Iran. METHODS AND
RESULTS: Despite the presence of all three serotypes of V.cholerae O1 (Ogawa, Inaba and Hikojima) in Iran in the last decade, the Inaba strains have been the dominated serotype. Sequence analysis of wbeT determined only a single substitution of G for A at position 295 in all Inaba strains resulting in a replacement of serine to proline. No difference was found in the copy numbers and profile of IS1004 between the classical and El Tor V. cholerae O1 strains, supporting the clonality amongst the isolates obtained over 5 years in Iran. In addition, Southern blots of HpaII-digested chromosomal DNAs of our Ogawa and Inaba isolates showed the presence of an incomplete copy of IS1004 for all isolates.
CONCLUSIONS: IS1004 profiling can be a reliable method for analysis of clonal dissemination of V. cholerae. The results indicated that specific point mutation at a particular position within the wbeT of V. cholerae O1 strains in Iran may occur which, in turn, may result in serotype switching. SIGNIFICANCE AND IMPACT OF THE STUDY: Understanding the molecular basis for serotype conversion of V. cholerae and their genetic relatedness could give insights for the incoming cholera epidemic prediction and control.
© 2012 The Authors. Letters in Applied Microbiology © 2012 The Society for Applied Microbiology.

Entities:  

Mesh:

Year:  2012        PMID: 22225492     DOI: 10.1111/j.1472-765X.2012.03204.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  7 in total

1.  Clonal Dissemination of a Single Vibrio cholerae O1 Biotype El Tor Strain in Sistan-Baluchestan Province of Iran During 2013.

Authors:  Bita Bakhshi; Azam Mahmoudi-Aznaveh; Ali Salimi-Khorashad
Journal:  Curr Microbiol       Date:  2015-04-11       Impact factor: 2.188

2.  Assessing clonal correlation of epidemic Vibrio cholerae isolates during 2011 in 16 provinces of Iran.

Authors:  Massoud Hajia; Mohamad Rahbar; Marjan Rahnamye Farzami; Hossein Masoumi Asl; Alireza Dolatyar; Mohsen Imani; Roghieh Saburian; Moharam Mafi; Bita Bakhshi
Journal:  Curr Microbiol       Date:  2014-11-26       Impact factor: 2.188

3.  Sequence polymorphisms of rfbT among the Vibrio cholerae O1 strains in the Ogawa and Inaba serotype shifts.

Authors:  Weili Liang; Luxi Wang; Pu Liang; Xiao Zheng; Haijian Zhou; Jingyun Zhang; Lijuan Zhang; Biao Kan
Journal:  BMC Microbiol       Date:  2013-07-26       Impact factor: 3.605

4.  Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.

Authors:  Stefan L Karlsson; Elisabeth Ax; Erik Nygren; Susanne Källgård; Margareta Blomquist; Annelie Ekman; John Benktander; Jan Holmgren; Michael Lebens
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Retrospective Analysis of Serotype Switching of Vibrio cholerae O1 in a Cholera Endemic Region Shows It Is a Non-random Process.

Authors:  Stefan L Karlsson; Nicholas Thomson; Ankur Mutreja; Thomas Connor; Dipika Sur; Mohammad Ali; John Clemens; Gordon Dougan; Jan Holmgren; Michael Lebens
Journal:  PLoS Negl Trop Dis       Date:  2016-10-05

6.  Lessons learned from past cholera epidemics, interventions which are needed today.

Authors:  Kamran B Lankarani; Seyed Moayed Alavian
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

7.  Genome Dynamics of Vibrio cholerae Isolates Linked to Seasonal Outbreaks of Cholera in Dhaka, Bangladesh.

Authors:  Ramani Baddam; Nishat Sarker; Dilruba Ahmed; Razib Mazumder; Ahmed Abdullah; Rayhan Morshed; Arif Hussain; Suraiya Begum; Lubaba Shahrin; Azharul Islam Khan; Md Sirajul Islam; Tahmeed Ahmed; Munirul Alam; John D Clemens; Niyaz Ahmed
Journal:  mBio       Date:  2020-02-11       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.